Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Consensus Recommendation of “Hold” by Analysts

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have been assigned a consensus recommendation of “Hold” from the nine ratings firms that are covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $21.00.

Several brokerages have recently commented on SBRA. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Saturday, January 3rd. Cantor Fitzgerald started coverage on Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective for the company. Wells Fargo & Company boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, UBS Group initiated coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price on the stock.

Sabra Healthcare REIT Trading Up 1.0%

NASDAQ:SBRA opened at $19.24 on Friday. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $19.97. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19. The firm’s fifty day moving average is $19.03 and its 200-day moving average is $18.68. The firm has a market cap of $4.80 billion, a P/E ratio of 26.72, a P/E/G ratio of 1.17 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.37 by $0.01. The company had revenue of $190.04 million during the quarter, compared to the consensus estimate of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The company’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Equities analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.2%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio is currently 166.67%.

Institutional Trading of Sabra Healthcare REIT

A number of institutional investors have recently modified their holdings of SBRA. Founders Capital Management purchased a new position in shares of Sabra Healthcare REIT during the third quarter worth about $28,000. Danske Bank A S bought a new position in shares of Sabra Healthcare REIT in the 3rd quarter worth $30,000. Larson Financial Group LLC raised its position in shares of Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares in the last quarter. Covestor Ltd raised its position in shares of Sabra Healthcare REIT by 23,720.0% during the 3rd quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 2,372 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Sabra Healthcare REIT by 150.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 1,536 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.